尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Johnson Philip L. Insider active across 1 company, notably Jazz Pharmaceuticals plc. In total, 5 disclosures have been published. Activity tracked since 1 March 2024. The latest transaction was filed on 5 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Johnson Philip L is a declarant linked to Jazz Pharmaceuticals plc, where he is EVP & Chief Financial Officer. Across 5 filings in total, the sampled filings run from 2024-03-05 to 2026-03-09, with 0 EUR of buys and 150234 EUR of sells, and the most frequent transaction nature is Attribution.